Primary immunodeficiency with increased numbers of circulating B lymphocytes contrasting with hypogammaglobulinaemia

Expression of a functional Fas death receptor by human foetal motoneurons.

Neuroscience·2003

Structural and functional properties of membrane and secreted IgD.

Molecular immunology·2001

In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients.

Journal of neuroimmunology·2000

Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients.

Journal of autoimmunity·2000

Cross-reactivity of anti-galactocerebroside autoantibodies with a Trypanosoma brucei proteolipidic epitope.

Clinical and experimental immunology·2000

In vitro induction of nitric oxide synthase in astrocytes and microglia by Trypanosoma brucei brucei.

Parasite immunology·1999

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Serum Borrelia IgG as a rule-out test in suspected lyme neuroborreliosis: a large retrospective cohort study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Fab-Level LC-MS Assessment of Chain Pairing in Asymmetric Bispecific Antibodies Enabled by IdeS Digestion and Selective Hinge Reduction.

Pharmaceutical research·2026

Comparative and qualitative analysis of endoscopic unilateral laminectomy with bilateral decompression versus interbody fusion in the treatment of grade 1 degenerative lumbar spondylolisthesis.

Neurosurgical focus·2026

Artificial intelligence for rapid on-site evaluation of lymph node fine-needle aspiration: improving diagnostic efficiency and accuracy.

Frontiers in medicine·2026

High transmission risk of Human Immunodeficiency Virus in blood transfusions: A critical evaluation of blood bank serological tests in Mozambique.

PLOS global public health·2026

Evaluation of Prophylactic Negative Pressure Therapy in the Murine Hindlimb Lymphedema Model.

Journal of vascular research·2026

Related Experiment Videos

Primary immunodeficiency with increased numbers of circulating B lymphocytes contrasting with hypogammaglobulinaemia

Related Concept Videos

Expression of a functional Fas death receptor by human foetal motoneurons.

Structural and functional properties of membrane and secreted IgD.

In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients.

Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients.

Cross-reactivity of anti-galactocerebroside autoantibodies with a Trypanosoma brucei proteolipidic epitope.

In vitro induction of nitric oxide synthase in astrocytes and microglia by Trypanosoma brucei brucei.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Serum Borrelia IgG as a rule-out test in suspected lyme neuroborreliosis: a large retrospective cohort study.

Fab-Level LC-MS Assessment of Chain Pairing in Asymmetric Bispecific Antibodies Enabled by IdeS Digestion and Selective Hinge Reduction.

Comparative and qualitative analysis of endoscopic unilateral laminectomy with bilateral decompression versus interbody fusion in the treatment of grade 1 degenerative lumbar spondylolisthesis.

Artificial intelligence for rapid on-site evaluation of lymph node fine-needle aspiration: improving diagnostic efficiency and accuracy.

High transmission risk of Human Immunodeficiency Virus in blood transfusions: A critical evaluation of blood bank serological tests in Mozambique.

Evaluation of Prophylactic Negative Pressure Therapy in the Murine Hindlimb Lymphedema Model.

Related Experiment Videos

Primary immunodeficiency with increased numbers of circulating B lymphocytes contrasting with hypogammaglobulinaemia

Related Concept Videos

Related Articles